253 related articles for article (PubMed ID: 33954817)
1. What is known about palliative care in adult patients with allogeneic stem cell transplantation (allo-SCT)?
Simon ST; Pralong A; Hallek M; Scheid C; Holtick U; Herling M
Ann Hematol; 2021 Jun; 100(6):1377-1389. PubMed ID: 33954817
[TBL] [Abstract][Full Text] [Related]
2. Developing a supportive and palliative care intervention for patients with allogeneic stem cell transplantation: protocol of a multicentre mixed-methods study (allo-PaS).
Pralong A; Herling M; Holtick U; Scheid C; Hellmich M; Hallek M; Pauli B; Reimer A; Schepers C; Simon ST
BMJ Open; 2023 Aug; 13(8):e066948. PubMed ID: 37652589
[TBL] [Abstract][Full Text] [Related]
3. Long-term outcome after allogeneic stem-cell transplantation with reduced-intensity conditioning in patients with multiple myeloma.
El-Cheikh J; Crocchiolo R; Furst S; Stoppa AM; Ladaique P; Faucher C; Calmels B; Lemarie C; De Colella JM; Granata A; Coso D; Bouabdallah R; Chabannon C; Blaise D
Am J Hematol; 2013 May; 88(5):370-4. PubMed ID: 23460414
[TBL] [Abstract][Full Text] [Related]
4. Epstein-Barr virus (EBV) reactivation is a frequent event after allogeneic stem cell transplantation (SCT) and quantitatively predicts EBV-lymphoproliferative disease following T-cell--depleted SCT.
van Esser JW; van der Holt B; Meijer E; Niesters HG; Trenschel R; Thijsen SF; van Loon AM; Frassoni F; Bacigalupo A; Schaefer UW; Osterhaus AD; Gratama JW; Löwenberg B; Verdonck LF; Cornelissen JJ
Blood; 2001 Aug; 98(4):972-8. PubMed ID: 11493441
[TBL] [Abstract][Full Text] [Related]
5. Allogeneic stem cell transplantation for patients with mantle cell lymphoma who failed autologous stem cell transplantation: a national survey of the SFGM-TC.
Tessoulin B; Ceballos P; Chevallier P; Blaise D; Tournilhac O; Gauthier J; Maillard N; Tabrizi R; Choquet S; Carras S; Ifrah N; Guillerm G; Mohty M; Tilly H; Socie G; Cornillon J; Hermine O; Daguindau É; Bachy E; Girault S; Marchand T; Oberic L; Reman O; Leux C; Le Gouill S
Bone Marrow Transplant; 2016 Sep; 51(9):1184-90. PubMed ID: 27111043
[TBL] [Abstract][Full Text] [Related]
6. A reduced dose of fluconazole as primary antifungal prophylaxis is not associated with increased risk of invasive fungal infections after allogeneic stem cell transplantation from a HLA identical sibling.
Sarina B; Mariotti J; Bramanti S; Morabito L; Crocchiolo R; Rimondo A; Tordato F; Pocaterra D; Casari E; De Philippis C; Carlo-Stella C; Santoro A; Castagna L
Transpl Infect Dis; 2018 Aug; 20(4):e12906. PubMed ID: 29668124
[TBL] [Abstract][Full Text] [Related]
7. Outpatient reduced-intensity allogeneic stem cell transplantation for patients with refractory or relapsed lymphomas compared with autologous stem cell transplantation using a simplified method.
Gutiérrez-Aguirre CH; Ruiz-Argüelles G; Cantú-Rodríguez OG; González-Llano O; Jaime-Pérez JC; García-Rodríguez F; López-Otero A; Herrera-Garza JL; Gómez-Almaguer D
Ann Hematol; 2010 Oct; 89(10):1045-52. PubMed ID: 20490794
[TBL] [Abstract][Full Text] [Related]
8. Feasibility of a New Model of Care for Allogeneic Stem Cell Transplantation Recipients Facilitated by eHealth: The MY-Medula Pilot Study.
Redondo S; De Dios A; Gomis-Pastor M; Esquirol A; Aso O; Triquell M; Moreno ME; Riba M; Ruiz J; Blasco A; Tobajas E; González I; Sierra J; Martino R; García-Cadenas I
Transplant Cell Ther; 2023 Jun; 29(6):385.e1-385.e8. PubMed ID: 36948273
[TBL] [Abstract][Full Text] [Related]
9. Impact of New Drugs on the Long-Term Follow-Up of Upfront Tandem Autograft-Allograft in Multiple Myeloma.
Giaccone L; Evangelista A; Patriarca F; Sorasio R; Pini M; Carnevale-Schianca F; Festuccia M; Brunello L; Zallio F; Maffini E; Omedé P; Bringhen S; Mordini N; Fanin R; Ciccone G; Boccadoro M; Bruno B
Biol Blood Marrow Transplant; 2018 Jan; 24(1):189-193. PubMed ID: 28987930
[TBL] [Abstract][Full Text] [Related]
10. Comparison between autologous and allogeneic stem cell transplantation as salvage therapy for multiple myeloma relapsing/progressing after autologous stem cell transplantation.
Ikeda T; Mori K; Kawamura K; Mori T; Hagiwara S; Ueda Y; Kahata K; Uchida N; Tsukada N; Murakami S; Yamamoto M; Takahashi T; Ichinohe T; Onizuka M; Atsuta Y; Kanda Y; Okamoto S; Sunami K; Takamatsu H
Hematol Oncol; 2019 Dec; 37(5):586-594. PubMed ID: 31674032
[TBL] [Abstract][Full Text] [Related]
11. Hematopoietic stem cell graft manipulation as a mechanism of immunotherapy.
Talmadge JE
Int Immunopharmacol; 2003 Aug; 3(8):1121-43. PubMed ID: 12860168
[TBL] [Abstract][Full Text] [Related]
12. Characteristics and Impact of Post-Transplant Interdisciplinary Palliative Care Consultation in Older Allogeneic Hematopoietic Cell Transplant Recipients.
Lin RJ; Cohen AG; Stabler SM; Devlin SM; Elko TA; Maloy MA; Korc-Grodzicki B; Alexander K; Kramer D; Sanchez-Escamilla M; Castillo Flores N; Barker JN; Cho C; Dahi PB; Gyurkocza B; Papadopoulos EB; Perales MA; Politikos I; Ponce DM; Sauter CS; Scordo M; Shaffer BC; Shah GL; Tamari R; Young JW; Jakubowski AA; Giralt SA; Nelson JE
J Palliat Med; 2020 Dec; 23(12):1653-1657. PubMed ID: 32216649
[No Abstract] [Full Text] [Related]
13. Feasibility and Implementation of a Multimodal Supportive Care Program to Improve Outcomes in Older Patients Undergoing Allogeneic Stem Cell Transplantation.
Szewczyk NA; Ngo-Huang A; Soones TN; Adekoya LM; Fontillas RC; Ferguson JK; Gale-Capps HE; Kurse BC; Lindsay RJ; Ombres R; Rivera ZR; Gulbis AM; Neumann JL; Braveman BH; Marin D; Shigle TL; Whited L; Wallis WD; Sullivan H; Cao L; Champlin RE; Shpall E; Popat UR
Transplant Cell Ther; 2021 Dec; 27(12):1008-1014. PubMed ID: 34537421
[TBL] [Abstract][Full Text] [Related]
14. Dynamics of Torque Teno virus viremia could predict risk of complications after allogeneic hematopoietic stem cell transplantation.
Gilles R; Herling M; Holtick U; Heger E; Awerkiew S; Fish I; Höller K; Sierra S; Knops E; Kaiser R; Scheid C; Di Cristanziano V
Med Microbiol Immunol; 2017 Oct; 206(5):355-362. PubMed ID: 28702856
[TBL] [Abstract][Full Text] [Related]
15. Hematopoietic stem cell transplantation practice variation among centers in the Eastern Mediterranean Region (EMRO): Eastern Mediterranean Bone Marrow Transplantation (EMBMT) group survey.
Rasheed W; Ghavamzadeh A; Hamladji R; Ben Othman T; Alseraihy A; Abdel-Rahman F; Elhaddad A; Alabdulaaly A; Dennison D; Ibrahim A; Bazarbachi A; Bekadja MA; Mohamed SY; Adil SN; Ahmed P; Benchekroun S; Ramzi M; Jarrar M; Alimoghaddam K; Hussain F; Hamidieh A; Aljurf M
Hematol Oncol Stem Cell Ther; 2013 Mar; 6(1):14-9. PubMed ID: 23664600
[TBL] [Abstract][Full Text] [Related]
16. Myeloablative versus reduced intensity allogeneic stem cell transplantation for relapsed/refractory Hodgkin's lymphoma in recent years: a retrospective analysis of the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation.
Genadieva-Stavrik S; Boumendil A; Dreger P; Peggs K; Briones J; Corradini P; Bacigalupo A; Socié G; Bonifazi F; Finel H; Velardi A; Potter M; Bruno B; Castagna L; Malladi R; Russell N; Sureda A
Ann Oncol; 2016 Dec; 27(12):2251-2257. PubMed ID: 28007754
[TBL] [Abstract][Full Text] [Related]
17. Allogeneic stem cell transplantation after reduced-intensity conditioning in lymphoid malignancies.
Sureda A; Schmitz N
Ann Hematol; 2003 Jan; 82(1):1-13. PubMed ID: 12574957
[TBL] [Abstract][Full Text] [Related]
18. Preventing the adverse cardiovascular consequences of allogeneic stem cell transplantation with a multi-faceted exercise intervention: the ALLO-Active trial protocol.
Dillon HT; Saner NJ; Ilsley T; Kliman D; Spencer A; Avery S; Dunstan DW; Daly RM; Fraser SF; Owen N; Lynch BM; Kingwell BA; La Gerche A; Howden EJ
BMC Cancer; 2022 Aug; 22(1):898. PubMed ID: 35978289
[TBL] [Abstract][Full Text] [Related]
19. Late-onset noninfectious pulmonary complications after allogeneic stem cell transplantation are significantly associated with chronic graft-versus-host disease and with the graft-versus-leukemia effect.
Sakaida E; Nakaseko C; Harima A; Yokota A; Cho R; Saito Y; Nishimura M
Blood; 2003 Dec; 102(12):4236-42. PubMed ID: 12907447
[TBL] [Abstract][Full Text] [Related]
20. Postmortem examination of the kidney in allogeneic hematopoietic stem cell transplantation recipients: possible involvement of graft-versus-host disease.
Kusumi E; Kami M; Hara S; Hoshino J; Yamaguchi Y; Murashige N; Kishi Y; Shibagaki Y; Shibata T; Matsumura T; Yuji K; Masuoka K; Wake A; Miyakoshi S; Taniguchi S
Int J Hematol; 2008 Mar; 87(2):225-230. PubMed ID: 18264743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
